Effect of Rg1-based Supplementation on Exercise Training-induced Stem Cell Recruitments and Skeletal Muscle Adaptation in Women Aged > 60
Key claim: An Rg1-based supplement (Senactiv®) is being tested as an adjunct to long-term exercise training to enhance bone marrow-derived stem cell recruitment and skeletal muscle adaptation, with potential to help prevent sarcopenia and cognitive decline in women over 60.
Abstract
This study will provide novel insights into the role of bone marrow-derived stem cells in muscle adaptation to long-term exercise and advance our understanding of an Rg-1 based supplement-Senactiv® as a potential intervention for preventing sarcopenia and cognitive decline in older adults.
Why this matters
Ginsenoside Rg1 already has a small human RCT signal in older women showing amplified stem-cell and mitochondrial responses to a single resistance-exercise bout; this protocol extends that lever into a longer training-adjunct design using a branded commercial formulation (Senactiv®), pushing the Rg1-plus-exercise story from acute biopsy readouts toward chronic adaptation and functional endpoints relevant to sarcopenia. It is one of the few active trials probing whether a TCM-derived compound can meaningfully augment the training response that remains the highest-tier lever in this area.